Pages that link to "Q28142963"
Jump to navigation
Jump to search
The following pages link to A review of central 5-HT receptors and their function (Q28142963):
Displaying 50 items.
- Decreased tryptophan metabolism in patients with autism spectrum disorders (Q21198692) (← links)
- DARPP-32 mediates the actions of multiple drugs of abuse (Q22241668) (← links)
- Flibanserin and 8-OH-DPAT implicate serotonin in association between female marmoset monkey sexual behavior and changes in pair-bond quality. (Q22242315) (← links)
- Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists (Q22251267) (← links)
- Toward selective drug development for the human 5-hydroxytryptamine 1E receptor: a comparison of 5-hydroxytryptamine 1E and 1F receptor structure-affinity relationships (Q24297642) (← links)
- Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients (Q24554505) (← links)
- The role of the hippocampus in the pathophysiology of major depression (Q24561923) (← links)
- Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat (Q24564955) (← links)
- A safe lithium mimetic for bipolar disorder (Q24600175) (← links)
- Neurobiological Underpinnings of the Estrogen - Mood Relationship (Q24630024) (← links)
- Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs (Q24630309) (← links)
- TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity (Q24631419) (← links)
- Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone (Q24633449) (← links)
- Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction (Q24641896) (← links)
- 5-HT(1A) receptor function in major depressive disorder (Q24643511) (← links)
- Guinea pig hippocampal 5-HT(1E) receptors: a tool for selective drug development (Q24643885) (← links)
- The bright side of being blue: depression as an adaptation for analyzing complex problems (Q24645463) (← links)
- Trace amine-associated receptor 1 as a monoaminergic modulator in brain (Q24650242) (← links)
- A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning (Q24651403) (← links)
- CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa (Q24655494) (← links)
- Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function (Q24655830) (← links)
- Mechanisms intrinsic to 5-HT2B receptor-induced potentiation of NMDA receptor responses in frog motoneurones (Q24671497) (← links)
- Flibanserin, a potential antidepressant drug, lowers 5-HT and raises dopamine and noradrenaline in the rat prefrontal cortex dialysate: role of 5-HT(1A) receptors (Q24672474) (← links)
- Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex (Q24676304) (← links)
- Role of the serotonin 5-HT(2A) receptor in learning (Q24685023) (← links)
- Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling (Q24810873) (← links)
- Serotonergic systems targeted by developmental exposure to chlorpyrifos: effects during different critical periods (Q24816699) (← links)
- Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT (Q26749755) (← links)
- Hippocampal 5-HT1A Receptor and Spatial Learning and Memory (Q26773111) (← links)
- Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome (Q26776222) (← links)
- The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory (Q26795511) (← links)
- Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities (Q26799997) (← links)
- Activities and Effects of Ergot Alkaloids on Livestock Physiology and Production (Q26801490) (← links)
- Adenosine-to-inosine RNA editing and human disease (Q26853110) (← links)
- Pharmacology of serotonin and female sexual behavior (Q26861672) (← links)
- Identifying serotonergic mechanisms underlying the corticolimbic response to threat in humans (Q26864503) (← links)
- Pharmacotherapy of amphetamine-type stimulant dependence: an update (Q26991936) (← links)
- Rediscovery of nefopam for the treatment of neuropathic pain (Q26998691) (← links)
- The role of serotonin in the regulation of patience and impulsivity (Q27013970) (← links)
- Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders (Q27014825) (← links)
- Neuropsychopharmacology and neurogenetic aspects of executive functioning: should reward gene polymorphisms constitute a diagnostic tool to identify individuals at risk for impaired judgment? (Q27024858) (← links)
- Effects of a Flavonoid-Rich Fraction on the Acquisition and Extinction of Fear Memory: Pharmacological and Molecular Approaches (Q27321760) (← links)
- Sensory neuron-derived eph regulates glomerular arbors and modulatory function of a central serotonergic neuron (Q27323228) (← links)
- Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases (Q28066691) (← links)
- A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction (Q28068256) (← links)
- Can the Lateral Habenula Crack the Serotonin Code? (Q28071548) (← links)
- Neuromodulation of the Feedforward Dentate Gyrus-CA3 Microcircuit (Q28076087) (← links)
- Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link? (Q28080944) (← links)
- The characterization, current medications, and promising therapeutics targets for premature ejaculation (Q28081739) (← links)
- Anandamide inhibits the DOI-induced head-twitch response in mice (Q28165866) (← links)